Ledger.Open graph →
SEC Form D · filed January 26, 2017

Vivex Biomedical, Inc

Offering
$5.0M
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Atlanta, GA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (34)

Barry T. Salzman · Atlanta, GADirectorJ. M. Fernandez De Castro · Atlanta, GADirectorTimothy T. Ganey, Ph.D · Atlanta, GAExecJames K. Price · Atlanta, GADirectorTracy S. Anderson · Atlanta, GAExec · DirectorTimothy S. Taylor · Atlanta, GADirectorJohn A. Mccallum · Atlanta, GADirectorU. B. Ellis, Jr · Atlanta, GADirectorHolly S. Mason · Atlanta, GAExecDr. H T. Temple · Atlanta, GAExecRichard E. Perlman · Atlanta, GADirectorMary Ann M. Sigler · Beverly Hills, CAExecPaul Lee · San Francisco, CADirectorMichael M. Sobel · NEW YORK, NYExec · DirectorJim Kim · San Francisco, CADirectorPhilip M. Desantis · New York, NYDirectorDerek L. Ross · Boston, MADirectorChristian M. Lange · NEW YORK, NYExecMatthew M. Danzeisen · NEW YORK, NYDirectorRonald M. Mateo · NEW YORK, NYDirectorDaniel M. Siracuse · New York, NYExecLeo S. Cook · Atlanta, GAExecPeter L. Slavin · Boston, MADirectorStanley L. Morten · Boston, MAExecBrendan F. O'Grady · Boston, MAExecNazim L. Cetin · Boston, MADirectorBradford F. Gay · Boston, MADirectorIdo Schoenberg · Boston, MAExec · DirectorDeval F. Patrick · Boston, MADirectorJohn F. Jesser · Boston, MADirectorRoy Schoenberg · Boston, MAExecGeoffrey T. Gentile · New York, NYDirectorColin T. Moran · New York, NYDirectorLeo S. Cook · Atlanta, GAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗